EPO (epoetin) approval stirs cost concern in Congress
- PMID: 10293460
Item in Clipboard
EPO (epoetin) approval stirs cost concern in Congress
Mod Healthc.
.
No abstract available
Similar articles
-
EPO--one year later. Fighting anemia in the courtroom.Nephrol News Issues. 1990 May;4(5):27. Nephrol News Issues. 1990. PMID: 2348877 No abstract available.
-
Evolution of recombinant human erythropoietin usage in clinical practice in the United States. Is there an optimal way to use rHuEPO?ASAIO J. 1993 Jan-Mar;39(1):11-8. ASAIO J. 1993. PMID: 8439674 Review. No abstract available.
-
FDA approves new epoetin product: Roche unsure when it can market in United States.Am J Health Syst Pharm. 2008 Jan 1;65(1):10. doi: 10.2146/news080001. Am J Health Syst Pharm. 2008. PMID: 18159030 No abstract available.
-
EPO--one year later. Effects of EPO on nutritional status in CRF.Nephrol News Issues. 1990 May;4(5):26, 34. Nephrol News Issues. 1990. PMID: 2348876 No abstract available.
-
Erythropoietin, an update, and where to in the future?EDTNA ERCA J. 1998 Jul-Sep;24(3):30-2, 35. EDTNA ERCA J. 1998. PMID: 10392076 Review.
Cited by
-
Epoetin: a pharmacoeconomic review of its use in chronic renal failure and its effects on quality of life.Pharmacoeconomics. 1993 Jan;3(1):45-82. doi: 10.2165/00019053-199303010-00006. Pharmacoeconomics. 1993. PMID: 10146987 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials